Antibody Analytics Revenue and Competitors
Estimated Revenue & Valuation
- Antibody Analytics's estimated annual revenue is currently $15.5M per year.
- Antibody Analytics's estimated revenue per employee is $155,000
Employee Data
- Antibody Analytics has 100 Employees.
- Antibody Analytics grew their employee count by 30% last year.
Antibody Analytics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Quality Officer | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Director Operations | Reveal Email/Phone |
5 | Director Biophysics | Reveal Email/Phone |
6 | Director Molecular Biology | Reveal Email/Phone |
7 | Chief Business Officer | Reveal Email/Phone |
8 | Junior Quality Officer | Reveal Email/Phone |
9 | Senior Study Manager | Reveal Email/Phone |
10 | Senior Study Manager | Reveal Email/Phone |
Antibody Analytics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $23.4M | 151 | -6% | N/A | N/A |
What Is Antibody Analytics?
At Antibody Analytics we believe that scientists deserve the best data, and patients deserve the best drugs. Led by a group of talented and engaged scientists, we look at biological problems in an openminded way to deliver beautifully designed, developed and qualified bioassays. We have developed a comprehensive portfolio of assays and platforms that can be tailored to support even the most complex of drug pipelines. Whether designing and developing bespoke bioassays or offering routine analysis on our already established assay platforms, Antibody Analytics has an exceptional track record of delivering beautiful results. http://www.antibodyanalytics.com
keywords:N/A
N/A
Total Funding
100
Number of Employees
$15.5M
Revenue (est)
30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Antibody Analytics News
North America Analytical Instrumentation Market - Growth, Trends, COVID-19 Impact, ... perform intact monoclonal antibody analysis,...
... Analytics to its Antibody Discovery Capabilities and Offerings ... driving the development of safe and effective antibody therapies.
The biotech's monoclonal antibody, dubbed ADG20, is in a phase 2/3 study with data analysis expected to be complete before the end of March.
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $32.8M | 100 | 6% | N/A |
#2 | $32.8M | 100 | -3% | N/A |
#3 | $30.5M | 100 | 8% | N/A |
#4 | $15.5M | 100 | 4% | N/A |
#5 | $14.5M | 100 | N/A | N/A |